| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC31A2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | CCDC140 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | ATP5F1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | FRS3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | RTN1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | RFC4 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | NKRF | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | OR6Q1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ASCC2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GNB3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
